Molecular mechanisms responsible for SARS-CoV-2 antibody waning and vaccine escape in Omicron sublineages BA.4 and BA.5

Mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome continue to threaten the global landscape of the coronavirus disease 2019 (COVID-19) pandemic. The Omicron variant (B.1.1.529) rapidly displaced previous ‘variants of concern’ (VoC) in 2021 due to its high rate of...

Full description

Bibliographic Details
Published in:	Journal of Infection in Developing Countries
Main Authors:	Benjamin Hewins, Christopher Richardson, Salvatore Rubino, Alyson Kelvin, Ali Toloue Ostadgavahi, David J Kelvin
Format:	Article
Language:	English
Published:	The Journal of Infection in Developing Countries 2022-07-01
Subjects:	Vaccination fatigue vaccine-variant mismatch antibody escape variants of concern (VoCs) breakthrough infection
Online Access:	https://jidc.org/index.php/journal/article/view/17010

Similar Items

Alpha, Beta, Delta, Omicron, and SARS-CoV-2 Breakthrough Cases: Defining Immunological Mechanisms for Vaccine Waning and Vaccine-Variant Mismatch
by: Benjamin Hewins, et al.
Published: (2022-05-01)

Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyResearch in context
by: Ralf Duerr, et al.
Published: (2023-11-01)

Continued Complexity of Mutations in Omicron Sublineages
by: Austin N. Spratt, et al.
Published: (2022-10-01)

Genomic Insights into Vaccine Evasion: A Cross-sectional Study from a Tertiary Care Hospital of Northern India
by: Uksim Qadri, et al.
Published: (2025-11-01)

The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far
by: Vivek P. Chavda, et al.
Published: (2022-11-01)

SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated Individuals
by: Maarten E. Emmelot, et al.
Published: (2022-12-01)

Immunogenicity and Breakthrough Outcomes of mRNA Booster Strategies Among Healthcare Workers During the BA.1/BA.2 Omicron Surge
by: Song Mi Moon, et al.
Published: (2025-10-01)

Estimation of mRNA COVID-19 Vaccination Effectiveness in Tokyo for Omicron Variants BA.2 and BA.5: Effect of Social Behavior
by: Sachiko Kodera, et al.
Published: (2022-10-01)

Comparative Analysis of Vaccine-Induced Neutralizing Antibodies against the Alpha, Beta, Delta, and Omicron Variants of SARS-CoV-2
by: Philipp Girl, et al.
Published: (2024-05-01)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
by: Iris Medits, et al.
Published: (2022-07-01)

Salivary antibodies induced by BA.4/BA.5-convalescence or bivalent booster Immunoglobulin vaccination protect against novel SARS-COV-2 variants of concern
by: Gabriel Diem, et al.
Published: (2023-10-01)

Iota-Carrageenan Inhibits Replication of the SARS-CoV-2 Variants of Concern Omicron BA.1, BA.2 and BA.5
by: Christian Setz, et al.
Published: (2023-07-01)

Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022
by: Pedro Dutra Drummond, et al.
Published: (2023-10-01)

Mutational dynamics of SARS-CoV-2: Impact on future COVID-19 vaccine strategies
by: Niloofar Faraji, et al.
Published: (2024-05-01)

Serial infection with SARS-CoV-2 Omicron BA.1 and BA.2 following three-dose COVID-19 vaccination
by: Hope R. Lapointe, et al.
Published: (2022-09-01)

Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
by: Rajkumar Chinnadurai, et al.
Published: (2022-03-01)

Multi-omic characteristics of longitudinal immune profiling after breakthrough infections caused by Omicron BA.5 sublineagesResearch in context
by: Yanhua Li, et al.
Published: (2024-12-01)

Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice
by: Jian Liu, et al.
Published: (2023-12-01)

SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
by: Elisa Regenhardt, et al.
Published: (2023-05-01)

Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
by: Shohei Yamamoto, et al.
Published: (2023-05-01)

Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil
by: Svetoslav Nanev Slavov, et al.
Published: (2022-09-01)

Clinical Characteristics, Breakthrough Infections, and Reinfections with SARS CoV-2 among Healthcare Workers in the Omicron Wave
by: Reyaz Ahmed Khan, et al.
Published: (2025-06-01)

Association Between mRNA Vaccination and Infection From SARS-CoV-2 During the Delta and Omicron BA.1 Waves: A Population-Level Analysis
by: Allison P. Plaxco, MPH, et al.
Published: (2023-12-01)

nSARS-CoV-2 and COVID-19 Pandemic: From Emergence to Vaccination
by: Imran Shahid
Published: (2022-01-01)

The Omicron Lineages BA.1 and BA.2 (<i>Betacoronavirus</i> SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub
by: Alessandra P. Lamarca, et al.
Published: (2023-03-01)

Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant
by: Mengist HM, et al.
Published: (2022-07-01)

Declining Levels of Neutralizing Antibodies to SARS-CoV-2 Omicron Variants Are Enhanced by Hybrid Immunity and Original/Omicron Bivalent Vaccination
by: Sharon Walmsley, et al.
Published: (2024-05-01)

Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico
by: Blanca Taboada, et al.
Published: (2022-05-01)

Risk factors for SARS-CoV-2 infection during the early stages of the COVID-19 pandemic: a systematic literature review
by: Matthew Harris, et al.
Published: (2023-07-01)

Sequential viral introductions and spread of BA.1 across Pakistan provinces during the Omicron wave
by: Ali Raza Bukhari, et al.
Published: (2023-08-01)

Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study
by: Xiaofeng He, et al.
Published: (2023-10-01)

Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series
by: Sally Aman Nasution, et al.
Published: (2022-07-01)

Confirmed Delta Variant COVID-19 Infection at A Single Centre Tertiary Hospital: A Case Series
by: Sally Aman Nasution, et al.
Published: (2022-04-01)

A DNA Vaccine Encoding the Full-Length Spike Protein of Beta Variant (B.1.351) Elicited Broader Cross-Reactive Immune Responses against Other SARS-CoV-2 Variants
by: Gan Zhao, et al.
Published: (2023-02-01)

Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1
by: Yanping Hu, et al.
Published: (2023-12-01)

Analytical Sensitivity of Eight Different SARS-CoV-2 Antigen-Detecting Rapid Tests for Omicron-BA.1 Variant
by: Meriem Bekliz, et al.
Published: (2022-08-01)

Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
by: Alina Seidel, et al.
Published: (2023-03-01)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
by: Jing Zou, et al.
Published: (2022-08-01)

Navigating the COVID-19 Therapeutic Landscape: Unveiling Novel Perspectives on FDA-Approved Medications, Vaccination Targets, and Emerging Novel Strategies
by: Reham F. Barghash, et al.
Published: (2024-11-01)

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses
by: Patricia Pérez, et al.
Published: (2024-08-01)